Logo
x

Search category

Subscribe Now

All Posts by Date

Janssen(J&J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for its Gene Therapy Candidates

Janssen(J&J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for its Gene Therapy Candidates

  • February 1, 2019
Bayer Signs an Exclusive License Agreement with Kyoto University for Pulmonary Disorders

Bayer Signs an Exclusive License Agreement with Kyoto University for Pulmonary Disorders

  • February 1, 2019
Alexion Collaborates with Caelum Biosciences for its CAEL-101 to Treat Light Chain (AL) Amyloidosis

Alexion Collaborates with Caelum Biosciences for its CAEL-101 to Treat Light Chain (AL) Amyloidosis

  • February 1, 2019
Audentes Reports Next Phase Development of AT132 for X-linked Myotubular Myopathy (XLMTM) with RMAT Designation

Audentes Reports Next Phase Development of AT132 for X-linked Myotubular Myopathy (XLMTM) with RMAT Designation

  • February 1, 2019
ONO Signs a Research Collaboration with Repare Therapeutics for its Polθ Inhibitor Program

ONO Signs a Research Collaboration with Repare Therapeutics for its Polθ Inhibitor Program

  • February 1, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.